Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting

DOI: 10.4292/wjgpt.v9.i1.8

Keywords: Crohn’s disease, Ulcerative colitis, Infliximab, Azathioprine, Inflammatory bowel disease

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text